Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Proc Natl Acad Sci U S A
2002 Mar 19;996:3609-14. doi: 10.1073/pnas.052026799.
Show Gene links
Show Anatomy links
Abnormal accumulation of hyaluronan matrix diminishes contact inhibition of cell growth and promotes cell migration.
Itano N
,
Atsumi F
,
Sawai T
,
Yamada Y
,
Miyaishi O
,
Senga T
,
Hamaguchi M
,
Kimata K
.
???displayArticle.abstract???
Elevated hyaluronan biosynthesis and matrix deposition correlates with cell proliferation and migration. We ectopically expressed three isoforms of hyaluronan synthase (HAS1, HAS2, or HAS3) in nontransformed rat 3Y1 cells and observed a de novo, massive formation of a hyaluronan matrix that resulted in a partial loss of contact-mediated inhibition of cell growth and migration. All three HAS transfectants showed an enhanced motility in scratch wound assays, and a significant increase in their confluent cell densities. In high-density cultures, the HAS transfectants had a fibroblastic cell shape and markedly formed overlapping cell layers. This phenotype was more pronounced in the HAS2 transfectants than HAS1 or HAS3 transfectants, and occurred with significant alterations in the microfilament organization and N-cadherin distribution at the cell-cell border. Inhibition of a phosphatidylinositol 3-kinase (PI3-kinase) pathway resulted in reacquisition of the normal phenotype of HAS2 transfectants, suggesting that the intracellular PI3-kinase signaling regulates diminution of contact inhibition induced by formation of the massive hyaluronan matrix. Our observations suggest that hyaluronan and its matrix can modulate contact inhibition of cell growth and migration, and provide evidence for functional differences between hyaluronan synthesized by the different HAS proteins.
Bourguignon,
CD44 interaction with tiam1 promotes Rac1 signaling and hyaluronic acid-mediated breast tumor cell migration.
2000, Pubmed
Bourguignon,
CD44 interaction with tiam1 promotes Rac1 signaling and hyaluronic acid-mediated breast tumor cell migration.
2000,
Pubmed
Camenisch,
Disruption of hyaluronan synthase-2 abrogates normal cardiac morphogenesis and hyaluronan-mediated transformation of epithelium to mesenchyme.
2000,
Pubmed
Entwistle,
HA receptors: regulators of signalling to the cytoskeleton.
1996,
Pubmed
Hopwood,
Glycosaminoglycan synthesis by cultured human skin fibroblasts after transformation with simian virus 40.
1977,
Pubmed
Ichikawa,
Increased synthesis of hyaluronate enhances motility of human melanoma cells.
1999,
Pubmed
,
Xenbase
Ishimoto,
Studies of carcinogenesis by avian sarcoma viruses. II. Virus-induced increase in hyaluronic acid synthetase in chicken fibroblasts.
1966,
Pubmed
Itano,
Relationship between hyaluronan production and metastatic potential of mouse mammary carcinoma cells.
1999,
Pubmed
,
Xenbase
Itano,
Three isoforms of mammalian hyaluronan synthases have distinct enzymatic properties.
1999,
Pubmed
,
Xenbase
Kimata,
Increased synthesis of hyaluronic acid by mouse mammary carcinoma cell variants with high metastatic potential.
1983,
Pubmed
Kimura,
Rat cell line 3y1 and its virogenic polyoma- and sv40- transformed derivatives.
1975,
Pubmed
Knudson,
Hyaluronan-binding proteins in development, tissue homeostasis, and disease.
1993,
Pubmed
Kosaki,
Overproduction of hyaluronan by expression of the hyaluronan synthase Has2 enhances anchorage-independent growth and tumorigenicity.
1999,
Pubmed
Laurent,
Hyaluronan.
1992,
Pubmed
Levenberg,
p27 is involved in N-cadherin-mediated contact inhibition of cell growth and S-phase entry.
1999,
Pubmed
Liu,
Hyaluronan synthase 3 overexpression promotes the growth of TSU prostate cancer cells.
2001,
Pubmed
Oliferenko,
Hyaluronic acid (HA) binding to CD44 activates Rac1 and induces lamellipodia outgrowth.
2000,
Pubmed
Orford,
Exogenous expression of beta-catenin regulates contact inhibition, anchorage-independent growth, anoikis, and radiation-induced cell cycle arrest.
1999,
Pubmed
Pienimaki,
Epidermal growth factor activates hyaluronan synthase 2 in epidermal keratinocytes and increases pericellular and intracellular hyaluronan.
2001,
Pubmed
Serbulea,
Hyaluronan activates mitogen-activated protein kinase via Ras-signaling pathway.
1999,
Pubmed
Simpson,
Hyaluronan synthase elevation in metastatic prostate carcinoma cells correlates with hyaluronan surface retention, a prerequisite for rapid adhesion to bone marrow endothelial cells.
2001,
Pubmed
,
Xenbase
Slevin,
Angiogenic oligosaccharides of hyaluronan induce protein tyrosine kinase activity in endothelial cells and activate a cytoplasmic signal transduction pathway resulting in proliferation.
1998,
Pubmed
Sohara,
Hyaluronan activates cell motility of v-Src-transformed cells via Ras-mitogen-activated protein kinase and phosphoinositide 3-kinase-Akt in a tumor-specific manner.
2001,
Pubmed
Spicer,
Characterization and molecular evolution of a vertebrate hyaluronan synthase gene family.
1998,
Pubmed
,
Xenbase
St Croix,
E-Cadherin-dependent growth suppression is mediated by the cyclin-dependent kinase inhibitor p27(KIP1).
1998,
Pubmed
Turley,
Glycosaminoglycan production by murine melanoma variants in vivo and in vitro.
1985,
Pubmed
Vleminckx,
Enlarged cell-associated proteoglycans abolish E-cadherin functionality in invasive tumor cells.
1994,
Pubmed
Weigel,
Hyaluronan synthases.
1997,
Pubmed
,
Xenbase
